ASCO GU Symposium
Date: February 14-16Location: Orlando, FL
Iris Personalized Medicine, a division of Iris International, is dedicated to enabling the advancement of predictive and personalized cancer treatment options. To find out more about Iris Personalized Medicine, click here.

Iris Personalized Medicine introduces NADiA ProsVue, a novel, personalized approach that peers through the cloud of imprecise information to provide a clearer view of the risk of clinical recurrence of prostate cancer for each patient. To find out more about the NADiA technology click here.